CMS reinstates enforcement discretion under CLIA for certain SARS-CoV-2 tests
During the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, the Centers for Medicare & Medicaid Services announced Friday. The decision rescinds a Sept. 26 memorandum that ended the 2020 enforcement discretion policy.
Related News Articles
Headline
The ongoing measles outbreak in Pennsylvania has reached 1,260 confirmed cases, the Pennsylvania Department of Health announced Oct. 16. Of those, 238…
Headline
CDC issues reminder on ending of the emergency authorization for COVID-19 in vitro diagnostics tests
The Centers for Disease Control and Prevention issued a reminder Oct. 14 that the declaration supporting the emergency use of COVID-19 in vitro diagnostics…
Headline
The Pennsylvania Department of Health announced Oct. 5 that the state has reached 1,004 confirmed measles cases this year. There have been 27 new positive…
Headline
A fifth measles-associated death was recorded in Pennsylvania, the state’s Department of Health announced Sept. 30. The department said the individual was…
Headline
The Pennsylvania Department of Health Sept. 15 announced the confirmation of two additional measles-associated deaths, bringing the state’s total to four. The…
Headline
A multistate cyclospora outbreak linked to iceberg lettuce has been declared over, the Centers for Disease Control and Prevention and Food and Drug…